How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

被引：0
|
作者：
Mikyung Kelly Seo
John Cairns
机构：
[1] London School of Hygiene and Tropical Medicine,Department of Health Services Research and Policy, Faculty of Public Health and Policy
[2] University of Bergen,Centre for Cancer Biomarkers (CCBIO)
[3] Department of Surgery and Cancer,undefined
[4] Faculty of Medicine,undefined
[5] Imperial College London,undefined
[6] Department of Public Health and Primary Care,undefined
[7] School of Clinical Medicine,undefined
[8] University of Cambridge,undefined
来源：
BMC Cancer | / 21卷
关键词：
Biomarker; Companion biomarker; Companion diagnostic; Precision medicine; Targeted therapy; Oncology; Cancer; Economic evaluation; Health economics; Cost-effectiveness; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cost-effectiveness of orthodontics: a systematic review
    Jermyn, Owen
    Bister, Dirk
    Jin, Huajie
    [J]. EUROPEAN JOURNAL OF ORTHODONTICS, 2022, 44 (05) : 566 - 577
  • [42] A systematic review on the cost-effectiveness of statins
    Franco, O
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 463 - 463
  • [43] Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review
    Mucherino, Sara
    Lorenzoni, Valentina
    Triulzi, Isotta
    Del Re, Marzia
    Orlando, Valentina
    Capuano, Annalisa
    Danesi, Romano
    Turchetti, Giuseppe
    Menditto, Enrica
    [J]. CANCERS, 2024, 16 (05)
  • [44] A Systematic Review on Cost-Effectiveness Studies Evaluating HPV Self-Testing for Cervical Cancer Screening
    Hallsson, Lara Run
    Haaf, Leonie Heloiese
    Hillemanns, Peter
    Jentschke, Matthias
    Siebert, Uwe
    Sroczynski, Gaby
    [J]. MEDICAL DECISION MAKING, 2024, 44 (02) : NP217 - NP219
  • [45] OUTPATIENT TOTAL SHOULDER ARTHROPLASTY A Systematic Review Evaluating Outcomes and Cost-Effectiveness
    Vajapey, Sravya P.
    Contreras, Erik S.
    Neviaser, Andrew S.
    Bishop, Julie Y.
    Cvetanovich, Gregory L.
    [J]. JBJS REVIEWS, 2021, 9 (05)
  • [46] Can we afford the future: effectiveness or cost-effectiveness as the criterion for introducing new therapies for breast cancer?
    Tannock, I. F.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 51 - 51
  • [47] Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature
    Yamamoto, David
    Campbell, Jonathan D.
    [J]. AUTOIMMUNE DISEASES, 2012, 2012
  • [48] COST-EFFECTIVENESS OF CURRENT THERAPIES IN PRIMARY BILIARY CIRRHOSIS: A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE
    Pells, G.
    Jones, D.
    Vale, L.
    [J]. GUT, 2015, 64 : A195 - A195
  • [49] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Alyson W. Wong
    John Koo
    Christopher J. Ryerson
    Mohsen Sadatsafavi
    Wenjia Chen
    [J]. BMC Pulmonary Medicine, 22
  • [50] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Wong, Alyson W.
    Koo, John
    Ryerson, Christopher J.
    Sadatsafavi, Mohsen
    Chen, Wenjia
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
12345